About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.91 (-2.19%)
PBM NASDAQ Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. Common Shares share price
PBM price activity
Último preço
$ 4,910
Variação (24h)
-0,11 USD (-2,19%)
Volume
15.06K
Volume (média 4 sem.)
-
Abertura
$ 4,92
Variação do dia
$ 4,84 - $ 5,10
Fechamento anterior
$ 5,02
Último negócio
07 Oct, 7:54 pm GMT+0
Atrasado
07 Oct, 7:54 pm GMT+0
PBM price performance
Atrasado
07 Oct, 7:54 pm GMT+0
quote.marketSignals